About Guselkumab
Class: | Interleukin-23 (IL-23) inhibitor
Use: | Treatment of moderate to severe plaque psoriasis in adults, active psoriatic arthritis, and active ankylosing spondylitis
Adult dose: | Initial dose: 100 mg subcutaneously at week 0 and week 4, followed by maintenance dose of 100 mg every 8 weeks
Pediatric dose: | Safety and efficacy not established in pediatric patients under 18 years of age
Side effects: | Upper respiratory infections, injection site reactions, headache, fatigue, and nau
Drug Class
Interleukin-23 (IL-23) inhibitor
Uses & Indications
Treatment of moderate to severe plaque psoriasis in adults, active psoriatic arthritis, and active ankylosing spondylitis
Storage Requirements
Store in the refrigerator (2°C to 8°C or 36°F to 46°F); may be stored at room temperature (up to 25°C or 77°F) for up to 21 days; do not freeze
Manufacturer & Packaging
Manufacturer: Janssen Cilag International N.V. [Beerse;BELGIUM], Belgium
Package Size
1 Pre-filled Pen (2 mL)
Price & Supplier
Price in UAE: AED 23123.50
Dosage Information
Adult Dose
Initial dose: 100 mg subcutaneously at week 0 and week 4, followed by maintenance dose of 100 mg every 8 weeks
Pediatric Dose
Safety and efficacy not established in pediatric patients under 18 years of age
Side Effects
Upper respiratory infections, injection site reactions, headache, fatigue, and nausea
Contraindications & Precautions
Hypersensitivity to guselkumab or any component of the formulation; active infections, including tuberculosis
Important Warnings
Risk of serious infections; monitor for signs and symptoms of infection; may increase risk of malignancies; live vaccines should be avoided during treatment
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.